Showing results (2011-2020 of 2,046) with videos related to
Sort By:
Pageof 205
Allergy|February 13, 2022
AllergoOncology: Danger signals in allergology and oncology: A European Academy of Allergy and Clinical Immunology (EAACI) Position PaperChristoph Bergmann, Aurélie Poli, Ioana Agache, et al.Allergy|January 24, 2024
AllergoOncology: Biomarkers and refined classification for research in the allergy and glioma nexus-A joint EAACI-EANO position paperMichelle C Turner, Urszula Radzikowska, Denisa E Ferastraoaru, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 30, 2020
Genetic Alterations in the PI3K/AKT Pathway and Baseline AKT Activity Define AKT Inhibitor Sensitivity in Breast Cancer Patient-derived XenograftsAlbert Gris-Oliver, Marta Palafox, Laia Monserrat, et al.NPJ Digital Medicine|April 9, 2022
Cohort design and natural language processing to reduce bias in electronic health records researchShaan Khurshid, Christopher Reeder, Lia X Harrington, et al.Cancer Research Communications|August 18, 2023
Activating Inducible T-cell Costimulator Yields Antitumor Activity Alone and in Combination with Anti-PD-1 Checkpoint BlockadeSapna Yadavilli, Jeremy D Waight, Sara Brett, et al.Allergy|December 30, 2016
AllergoOncology - the impact of allergy in oncology: EAACI position paperE Jensen-Jarolim, H J Bax, R Bianchini, et al.The Journal of Infectious Diseases|July 27, 2022
Casirivimab and Imdevimab for the Treatment of Hospitalized Patients With COVID-19Selin Somersan-Karakaya, Eleftherios Mylonakis, Vidya P Menon, et al.The Lancet. Infectious Diseases|July 8, 2022
Efficacy and safety of a single dose of casirivimab and imdevimab for the prevention of COVID-19 over an 8-month period: a randomised, double-blind, placebo-controlled trialGary A Herman, Meagan P O'Brien, Eduardo Forleo-Neto, et al.The Lancet. Public Health|December 19, 2017
Population-level impact, herd immunity, and elimination after human papillomavirus vaccination: a systematic review and meta-analysis of predictions from transmission-dynamic modelsMarc Brisson, Élodie Bénard, Mélanie Drolet, et al.Nature Methods|December 23, 2025
Glutamate indicators with increased sensitivity and tailored deactivation ratesAbhi Aggarwal, Adrian Negrean, Yang Chen, et al.Pageof 205